SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
295.00
Ask:
295.40
Spread: 0.40 (0.136%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Board Changes

2 Dec 2019 07:00

RNS Number : 2201V
Breedon Group PLC
02 December 2019
 

 

 

 

2 December 2019

 

Breedon Group plc ("Breedon")

Board Changes

 

Breedon Group plc, a leading construction materials group in Great Britain and Ireland, has appointed Moni Mannings as an independent non-executive director with effect from 1 December 2019.

 

Moni has held several senior non-executive positions, including as a Board Member of the Solicitors Regulation Authority, non-executive director of Dairy Crest Group PLC and non-executive director and Chair of the Remuneration Committee of Polypipe Group PLC. She is currently Senior Independent Director and Chair of the Remuneration Committee of Investec Bank PLC.

 

Moni is a former Partner and Head of the International Banking & Finance Division of Olswang LLP, prior to which she held senior positions with Dewey Ballantine LLP and Simmons & Simmons. More recently, she was Chief Operating Officer of Aistemos Ltd, a leading IP data analytics and strategy company.

 

Having served on the Board of Breedon since its creation in 2008, David Williams will retire as a director on 31 December 2019. The Board would like to express its thanks to David for his support and counsel during the development of the Breedon Group. It is anticipated that Moni will succeed him as Chair of Breedon's Remuneration Committee upon his retirement.

 

David Williams commented: "Having served as a non-executive director and Chair of the Remuneration Committee since co-founding the company in 2008, I believe the time is now right to step down from the Board in accordance with best governance practice. I will therefore retire as a director at the end of this year. It has been an absolute pleasure to serve on Breedon's Board for the last 11 years and as I take my leave I am delighted that the company has attracted two such outstanding new non-executive directors in Moni Mannings and Clive Watson. I wish the company and its staff every success in the future."

 

Regulatory Disclosures

In the previous five years, Sheikh Mansurah Tal-At (Moni) Mannings (née Ahmad), aged 56, has been a director of the following entities:

 

Current directorships

Past directorships

Barnardo's, Charity

Investec Bank PLC

Investec Holdings (Ireland) Limited

Investec Europe Limited

The Felix Dennis Foundation, Charity

The St Marks Hospital Foundation, Charity

Aistemos Limited

BFWG Charitable Foundation

CMS Cameron Mckenna Nabarro Olswang (Singapore) LLP

Cranfield University

Dairy Crest Group PLC

Funds for Women Graduates, Charity

Investec Capital and Investments (Ireland) Limited

Olswang LLP

Olswang France LLP

Olswang Spain LLP

Polypipe Group PLC

Solicitors Regulation Authority

 

As at today's date, Ms Mannings does not hold any ordinary shares in Breedon.

 

There are no other details regarding the appointment of Ms Mannings that require disclosure under Schedule 2(g) of the AIM Rules for Companies.

 

- ends -

 

Note to editors

 

Breedon Group plc is a leading construction materials group in Great Britain and Ireland. It operates two cement plants and an extensive network of quarries, asphalt plants and ready-mixed concrete plants, together with slate production, concrete and clay products manufacturing, contract surfacing and highway maintenance operations. The Group employs nearly 3,000 people and has nearly 900 million tonnes of mineral reserves and resources. Its strategy is to continue growing organically and through the acquisition of businesses in the heavyside construction materials market.

 

 

 

For further information:

 

Breedon Group plc

Pat Ward, Group Chief Executive

Rob Wood, Group Finance Director 01332 694010

 

Stephen Jacobs, Head of Communications 07831 764592

 

Cenkos Securities (NOMAD and Joint Broker)

Max Hartley / Harry Hargreaves 020 7397 8900

 

Numis (Joint Broker)

Ben Stoop / Heraclis Economides 020 7260 1000

 

Teneo

Matt Denham / Rachel Miller 020 7420 3180

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABLBFTMBITBBL
Date   Source Headline
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.